The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.
Saved in:
| Title: | The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study. |
|---|---|
| Authors: | Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Staudt L; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA., Takebe N; Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, MD, USA., Wheeler DA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cardenas MF; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Korchina V; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Zenklusen JC; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA., McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Lubensky I; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., O'Sullivan-Coyne G; Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, MD, USA., Kohn E; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., White J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Malik S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Mann B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Weil C; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Tarnuzzer R; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA., Karlovich C; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Rodgers B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Shankar L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Jacobs PM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Nolan T; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Berryman SM; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Gastier-Foster J; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA., Bowen J; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA., Leraas K; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA., Shen H; Van Andel Research Institute, Grand Rapids, MI, USA., Laird PW; Van Andel Research Institute, Grand Rapids, MI, USA., Esteller M; Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, Spain., Miller V; Foundation Medicine Inc, Cambridge, MA, USA., Johnson A; Foundation Medicine Inc, Cambridge, MA, USA., Edmondson EF; Pathology and Histology Laboratory, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Giordano TJ; Department of Pathology, University of Michigan, Ann Arbor, MI, USA., Kim B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Ivy SP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 04; Vol. 113 (1), pp. 27-37. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
